Drug name…or Star Wars planet?
Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference.
02:04
Fri, Apr 10 20159:30 AM EDT
Similar Posts
North Korea claims H-bomb test successful
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email NBC’s Bill Neely reports analyst in South Korea confirmed there was a test but it could take weeks or months to determine what exactly happened underground. 02:21 Wed, Jan 6 20166:03 AM EST
CNBC PRO Talks: Morningstar’s chief U.S. strategist on stocks to beat the volatility
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dave Sekera, chief U.S market strategist for Morningstar, joined CNBC’s Julianna Tatelbaum on Wednesday for a frank conversation on the market outlook. 33:50 Wed, Jul 13 20229:16 AM EDT
Jim Cramer sees FTC Chair Lina Khan’s policies hurting investor portfolios
CNBC’s Jim Cramer said Federal Trade Commission chair Lina Khan’s attempts to stop mergers and acquisitions from going through is hurting stock portfolios in the process. “Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be, as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday….
There’s plenty of oil supply, says markets pro
The “Futures Now” team, Scott Nations and Jim Iuorio, discuss the wild day for crude oil after Trump denied Iran’s claim U.S. offered to remove sanctions with CNBC”s Rahel Solomon.
You’ll see very strong earnings from General Motors on Tuesday, says Benchmark’s Ward
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Michael Ward, The Benchmark Company auto analyst, and Garrett Nelson, CFRA senior auto analyst, join ‘Power Lunch’ to discuss the bull case for General Motors and Ford, Nelson’s thoughts on Ford in the mid- to long-term and more. 04:32 Mon, Oct 24…
Cramer’s Stop Trading: Nvidia
CNBC’s Jim Cramer explains why he is keeping an eye on shares of Nvidia.
